Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
Can high-protein supplements improve cancer recovery?
New evidence reveals that protein-rich oral supplements can support cancer recovery with fewer complications and shorter hospital stays,…
Electrical stimulation predicts recovery potential after acute nerve injuries
Bottom line: This study found that, in rats, acute nerve injuries that may recover can be distinguished from…
Early diagnosis and modern therapies improve Crohn’s disease prognosis
Crohn’s disease, a type of inflammatory bowel disease (IBD), impacts millions worldwide. The disease is chronic and highly…
World’s first 5G remote robotic surgery performed at extreme altitude in China
Published on 09/09/2025 – 7:03 GMT+2 ADVERTISEMENT At over 4,500 metres above sea level, in Nagqu City located…
New tool can predict where deadly brain cancer might reappear
Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
No clear benefit from surgical left atrial appendage occlusion in non-AF patients after valve surgery
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year…
Advances in ultrasound improve prenatal detection of congenital heart disease
A new study published in The Annals of Thoracic Surgery, the journal from The Society of Thoracic Surgeons, suggests…
Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial
Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
Society of Anaesthetists responds to increasing specialist fees
Almost a million Australians delay or skip specialist care because of the cost, according to a report by…